A Phase I Study of Sunitinib Malate [sunitinib] in Combination With Cisplatin and 5-Fluorouracil [fluorouracil] in Patients With Advanced Gastric Cancer.

Trial Profile

A Phase I Study of Sunitinib Malate [sunitinib] in Combination With Cisplatin and 5-Fluorouracil [fluorouracil] in Patients With Advanced Gastric Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Dec 2011

At a glance

  • Drugs Cisplatin; Fluorouracil; Sunitinib
  • Indications Gastric cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Nov 2010 Actual initiation date (Aug 2008) added as reported by ClinicalTrials.gov.
    • 19 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Aug 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top